A Hybrid Flu-COVID Messenger RNA Jab Will Be Ready Within Months – Moderna Reveals Human Trials
... the company is currently working on a “triple-threat” vaccine that will be made available sometime in 2024 or 2025
Exposing The Darkness is a reader-supported publication. To support my work, please consider becoming a paid subscriber.
By Geoffrey Grider June 21, 2022
VAX 2.0 – Moderna Announces That Human Trials Of New Hybrid Flu And COVID Messenger RNA Vaccine Are Officially Underway For Rollout In Late 2023
On Sunday, Moderna’s Chief Medical Officer Dr. Paul Burton announced the messenger RNA vaccine maker had officially kicked off phase 1 ‘human trials’ for its new two-in-one hybrid Flu-COVID jab.
Lol, so you thought that all this was going to just ‘go away’, right? That’s soooo funny, after having established that yes, the world will indeed line up to receive the government injection, the New World Order has the Willy Wonka Golden Ticket of end times shenanigans. Messenger RNA is here to stay, and it’s going to start popping up everywhere you look. Should you be afraid of the messenger? Absolutely, unless of course you like having your genes edited by messenger RNA.
“An evil man seeketh only rebellion: therefore a cruel messenger shall be sent against him.” Proverbs 17:11 (KJB)
Moderna has updated their logo to proudly feature the term ‘messenger therapeutics‘ front and center where everyone can read it, no more having to hide it. One of these old days, they will kick off human trials of a new messenger vaccine that will be injected into the back of your right hand, or injected into your forehead. When that happens, run.
Moderna Announces ‘Human Trials’ of New Hybrid Flu-Covid Vaccine Are Officially Underway
FROM THE GATEWAY PUNDIT: According to Burton, who spoke exclusively with 9News Australia, phase one clinical trials for the hybrid vaccine are currently underway and progressing on schedule, with the new treatment expected to be rolled out between late 2023 and early 2024.
“A phase one trial of a combination flu and Covid vaccine is currently underway. Moderna plans to have that vaccine ready by next year or by early 2024.”
Moderna’s CMO also announced that the company is currently working on a “triple-threat” vaccine that will be made available sometime in 2024 or 2025, following the rollout of the hybrid ‘Flu-Rona’ vaccine. The third-generation treatment will also target a lung infection called respiratory syncytial virus (RSV), which is a common, contagious virus that causes infections of the respiratory tract, according to the CDC.
Just like with Covid, RSV has an extremely low mortality rate for the vast majority of people. But, the sCiEnCe says we need another experimental vaccine – and you must take it. Initial “human trials” for this triple vaccine are also expected to begin by the end of this year.
“We have a three-in-one, which is Covid, Flu, and something called RSV. These are all respiratory pathogens that kill people young and old every year.”
Despite the undeniable failure of the vaccine’s effectiveness, Burton described the experimental hybrid treatment as necessary, especially in the face of the new Omicron subvariants that are spreading across the west. He promoted Moderna’s latest iteration of the mRNA vaccine – the also-failed, Omicron-specific boosters – as the temporary solution until the new version is rolled out next year. READ MORE
President of Bayer Pharmaceuticals Admits Messenger RNA Is
President of Bayer’s Pharmaceuticals Sector and member of the board said in his speech: ‘Ultimately the mRNA vaccines are an example for that cell and gene therapy. I always like to say: If we had surveyed two years ago in the public: ‘would you be willing to take a gene or cell therapy and inject it into your body?’ we probably would have had a 95% refusal rate”
This article was originally published on NowTheEndBegins.com
Important Players Behind Moderna’s mRNA Gene-Altering Abomination:
“Strategic alliances: DARPA, Biomedical Advanced Research and Development Authority (BARDA), and The Bill & Melinda Gates Foundation” - Moderna SEC Filing